Sangamo Therapeutics
SGMO
#9340
Rank
A$0.14 B
Marketcap
A$0.36
Share price
-4.66%
Change (1 day)
-69.02%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -A$0.18 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are A$32.87 Million. In 2024 the company made an earning of -A$0.14 Billion, an increase over its 2023 earnings that were of -A$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.18 Billion23.78%
2024 -A$0.14 Billion-17.27%
2023 -A$0.17 Billion-40.88%
2022 -A$0.29 Billion9.79%
2021 -A$0.26 Billion41.52%
2020 -A$0.19 Billion23.17%
2019 -A$0.15 Billion36.33%
2018 -A$0.11 Billion36.89%
2017 -A$78.71 Million-22.32%
2016 -A$0.11 Billion54.86%
2015 -A$65.44 Million75.62%
2014 -A$37.26 Million0.13%
2013 -A$37.22 Million
2011 -A$50.03 Million43.66%
2010 -A$34.83 Million28.52%
2009 -A$27.1 Million-23.55%
2008 -A$35.45 Million2.45%
2007 -A$34.6 Million19.5%
2006 -A$28.95 Million50.78%
2005 -A$19.2 Million75%
2004 -A$10.98 Million-33.25%
2003 -A$16.44 Million-62.27%
2002 -A$43.57 Million102.82%
2001 -A$21.48 Million23.21%
2000 -A$17.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.85 B-30,874.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.53 B-8,332.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.17 B-1,527.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-A$3.51 Billion 2,203.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$13.68 B-9,085.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$31.31 B-20,666.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$0.80 B-628.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.67 B-542.54%๐Ÿ‡บ๐Ÿ‡ธ USA